Cancer clinical trials in the region Bretagne
199 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 3
Breast cancer
#NCT04862663
#2023-504997-39-00
HER2 Negative
HR Positive
Locally Advanced
Metastatic
1
Hormone therapy
CARIO Imagerie Médicale site de Plérin (Plérin)
AstraZeneca
Phase 3
Lung cancer
#NCT05211895
#2023-506891-28-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
None
Chemotherapy
Radiotherapy
ALK
EGFR
Institut de Cancérologie Radiothérapie Brétillien / CHP Saint Grégoire - Vivalto Santé (Saint-Grégoire), Centre Hospitalier de Cornouaille (Quimper)
AstraZeneca
Phase 3
Prostate cancer
#NCT06276465
#2023-507482-26-00
Adenocarcinoma
Metastatic Castration-resistant
None
Surgery
Radiotherapy
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Groupe Hospitalier Bretagne Sud - Site de Lorient (Lorient)
UNICANCER
Phase 3
Colon cancer
Rectal cancer
#NCT05253651
#2024-514180-25-00
Adenocarcinoma
Locally Advanced
Metastatic
HER2
None
Systemic Treatment-Naive
KRAS G12C
KRAS non G12C
NRAS
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Seagen
Phase 3
Colon cancer
#NCT02355379
Adenocarcinoma
Locally Advanced
None
Systemic Treatment-Naive
Surgery
Chemotherapy
CARIO Imagerie Médicale site de Plérin (Plérin), Centre Hospitalier de Saint-Malo (Saint-Malo), Groupe Hospitalier Bretagne Sud - Site de Lorient (Lorient), Centre Hospitalier des Pays de Morlaix (Morlaix), CHU de Rennes - Hôpital Pontchaillou (Rennes) (and 2 more...)
Fédération Francophone de Cancérologie Digestive
Phase 3
Prostate cancer
#NCT06496581
Adenocarcinoma
Metastatic Hormone-sensitive
None
Hormone therapy
Systemic Treatment-Naive
Internal Vectorised Radiotherapy (IVR)
Centre Eugene Marquis (Rennes)
UNICANCER
Phase 3
Breast cancer
#NCT05633654
HER2 Negative
HR Negative
Localized
Locally Advanced
None
Surgery
Chemotherapy
Radiotherapy
Surgery
Chemotherapy
Radiotherapy
BRCA 1/2
Systemic Treatment-Naive
Immunotherapy
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Immunotherapy
Antibody Drug Conjugates (ADC)
Hôpital Privé des Côtes d'Armor (Plérin), Centre Eugene Marquis (Rennes)
Gilead Sciences
Phase 3
Breast cancer
#NCT05078047
HER2 Negative
HR Negative
Locally Advanced
Metastatic
Immunotherapy
Centre Eugene Marquis (Rennes)
UNICANCER
Phase 3
Liver and bile duct cancer
#NCT06813976
Ampullary carcinoma
Localized
None
Surgery
Centre Eugene Marquis (Rennes)
CHU Dijon
Phase 3
Breast cancer
#NCT06312176
HER2 Negative
HR Positive
Locally Advanced
Metastatic
1
2
3 or more
Targeted therapy
Hormone therapy
Systemic Treatment-Naive
Chemotherapy
Centre Eugene Marquis (Rennes)
Merck Sharp & Dohme LLC